RARA CRAFT DATABASE for FDA Medical Devices
510(k)K153345

FDA DEVICE FACTS

Stryker Orthopaedics Hip Systems Labeling Update

Stryker Orthopaedics

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEMay 25, 2016PRODUCT CODELPH

Indications for use

Painful, disabling joint disease of the hip resulting from: degenerative arthritis, rheumatoid arthritis, posttraumatic arthritis or late stage avascular necrosis. x Revision of previous unsuccessful femoral head replacement, cup arthroplasty or other procedure. x Clinical management problems where arthrodesis or alternative reconstructive techniques are less likely to achieve satisfactory results. x Where bone stock is of poor quality or is inadequate for other reconstructive techniques as indicated by deficiencies of the acetabulum. The Trident shells are intended for cementless fixation within the prepared acetabulum. Painful, disabling joint disease of the hip resulting from: degenerative arthritis, rheumatoid arthritis, posttraumatic arthritis or late stage avascular necrosis. x Revision of previous unsuccessful femoral head replacement, cup arthroplasty or other procedure. x Clinical management problems where arthrodesis or alternative reconstructive techniques are less likely to achieve satisfactory results. x Where bone stock is of poor quality or is inadequate for other reconstructive techniques as indicated by deficiencies of the acetabulum. The Tritanium Acetabular Shell System is intended for cementless use only. The indications for use for total hip arthroplasty with stems include: x noninflammatory degenerative joint disease, including osteoarthritis and avascular necrosis; x rheumatoid arthritis; x correction of functional deformity; x revision procedures where other treatments or devices have failed; and, x nonunions, femoral neck fractures, and trochanteric fractures of the proximal femur with head involvement that are unmanageable using other techniques. Additional indication specific to use of the Femoral Stem with compatible Howmedica Osteonics Constrained Liners: x When the stem is to be used with compatible Howmedica Osteonics Constrained Liners, the device is intended for use in primary or revision patients at high risk of hip dislocation due to a history of prior dislocation, bone loss, soft tissue laxity, neuromuscular disease, or intra-operative instability. Accolade II, Secur-Fit Advanced and Anato Femoral Stems are intended for cementless use only and are intended for total and hemiarthroplasty. The Exeter® V40™ Hip System is intended for use in total hip replacement. It is intended for cemented use only. The Exeter® Hip is indicated for: x noninflammatory degenerative joint disease, including osteoarthritis and avascular necrosis; x rheumatoid arthritis; x correction of functional deformity; x revision procedures where other treatments or devices have failed; and, x treatment of nonunion, femoral neck and trochanteric fractures of the proximal femur with head involvement that are unmanageable using other techniques. Painful, disabling joint disease of the hip resulting from: degenerative arthritis, rheumatoid arthritis, posttraumatic arthritis or late stage avascular necrosis. x Revision of previous unsuccessful femoral head replacement, cup arthroplasty or other procedure. x Clinical management problems where arthrodesis or alternative reconstructive techniques are less likely to achieve satisfactory results. x Where bone stock is of poor quality or is inadequate for other reconstructive techniques as indicated by deficiencies of the acetabulum. When used with MDM Liners x Treatment of nonunion, femoral neck and trochanteric fractures of the proximal femur with head involvement that are unmanageable using other techniques. x Dislocation risks When used with Constrained Liner: x The Trident Constrained Acetabular Insert is indicated for use in primary and revision patients at high risk of hip dislocation due to a history of prior dislocation, bone loss, joint or soft tissue laxity, neuromuscular disease, or intraoperative instability. The Restoration® Anatomic Shell is indicated for cementless use only. For use as a Bipolar Hip Replacement: x Femoral head/neck fractures or non-unions. x Aseptic necrosis of the femoral head. x Osteo-, rheumatoid, and post-traumatic arthritis of the hip with minimal acetabular involvement or distortion. Other Considerations: x Pathological conditions or age considerations which indicate a more conservative acetabular procedure and an avoidance of the use of bone cement in the acetabulum. x Salvage of failed total hip arthroplasty. x Femoral neck fractures. For use as a Total Hip Replacement: x Painful, disabling joint disease of the hip resulting from: degenerative arthritis, rheumatoid arthritis, post-traumatic arthritis or late stage avascular necrosis. x Revision of previous unsuccessful femoral head replacement, cup arthroplasty or other procedure. x Clinical management problems where arthrodesis or alternative reconstructive techniques are less likely to achieve satisfactory results. x Clinical circumstances which require an altered femoral resection level due to a proximal fracture, bone loss or calcar lysis. For use as a Bipolar Hip Replacement: x Femoral head/neck fractures or non-unions. x Aseptic necrosis of the femoral head. x Osteo-, rheumatoid, and post-traumatic arthritis of the hip with minimal acetabular involvement or distortion. Other Considerations: x Pathological conditions or age considerations which indicate a more conservative acetabular procedure and an avoidance of the use of bone cement in the acetabulum. x Salvage of failed total hip arthroplasty. For use as a Total Hip Replacement: x Painful, disabling joint disease of the hip resulting from: degenerative arthritis, rheumatoid arthritis, post-traumatic arthritis or late stage avascular necrosis. x Revision of previous unsuccessful femoral head replacement, cup arthroplasty or other procedure. x Clinical management problems where arthrodesis or alternative reconstructive techniques are less likely to achieve satisfactory results. Secur-Fit Max and Secur-Fit Max Plus Hip stems are single use devices and are intended for cementless fixation within the prepared femoral canals of patients requiring hip arthroplasty. Indications for use as a Total Hip Replacement include: x noninflammatory degenerative joint disease, including osteoarthritis and avascular necrosis; x rheumatoid arthritis; x correction of functional deformity; x revision procedures where other treatments or devices have failed; and, x treatment of nonunion, femoral neck and trochanteric fractures of the proximal femur with head involvement that are unmanageable using other techniques.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: September 2, 2026